BPBT
NYMX

Boston Private Bank & Trust’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Boston Private Bank & Trust’s Portfolio NYMX Stock Details NYMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-50
Closed – – 1091
2013
Q4 		$0 Buy
+50
New +$341 ﹤0.01% 1095

Other funds holding NYMX

Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
WP
WMS Partners Towson, Maryland $1.78B AUM 11.82% 1-Year Est. Return
SKK
Shepherd Kaplan Krochuk Boston, Massachusetts $119M AUM 8.32% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
MCM
Marathon Capital Management Hunt Valley, Maryland $494M AUM 42.6% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
EVC
Eidelman Virant Capital Saint Louis, Missouri $136M AUM 15.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GG
Gofen & Glossberg Chicago, Illinois $3.89B AUM 11.97% 1-Year Est. Return

Boston Private Bank & Trust's NYMX Position: Q1 2014 in Review

Boston Private Bank & Trust sold out of Nymox Pharmaceutical Corp (NYMX) in Q1 2014, closing a stake of 50 shares.

Boston Private Bank & Trust first reported a position in NYMX in Q4 2013 and held it in 1 quarter. The position peaked at $0 in Q4 2013. 32 funds tracked by Wall St. Rank hold NYMX as of Q1 2014.

  • Boston Private Bank & Trust reported no remaining Nymox Pharmaceutical Corp position as of Q1 2014 after selling out during the quarter.
  • Boston Private Bank & Trust sold 50 Nymox Pharmaceutical Corp shares in Q1 2014.
  • Boston Private Bank & Trust first reported a position in Nymox Pharmaceutical Corp in Q4 2013 and held it in 1 quarter.
  • Boston Private Bank & Trust's Nymox Pharmaceutical Corp position peaked at $0 in Q4 2013.
  • 32 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q1 2014.

Based on Boston Private Bank & Trust's 13F filing for Q1 2014, filed 15 Apr 2014.